Eli Lilly & Co (LLY) Price & Analysis

Compare

16,331 Followers

LLY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$677.09 - $972.53

Previous CloseN/A

Volume1.27M

Average Volume (3M)4.58M

Market Cap

$676.41B

Enterprise Value$711.83B

Total Cash (Recent Filing)$3.22B

Total Debt (Recent Filing)$38.52B

Price to Earnings (P/E)59.1

Beta0.68

Next Earnings

Aug 07, 2025

EPS Estimate

5.54

Last Dividend Ex-Date

May 16, 2025

Dividend Yield0.76%

Share Statistics

EPS (TTM)3.34

Shares Outstanding947,735,660

10 Day Avg. Volume4,999,827

30 Day Avg. Volume4,580,355

Financial Highlights & Ratios

PEG Ratio11.69

Price to Book (P/B)40.69

Price to Sales (P/S)0.00

P/FCF Ratio557.27

Enterprise Value/Market Cap1.05

Enterprise Value/Revenue4.09

Enterprise Value/Gross Profit17.78

Enterprise Value/Ebitda12.89

Forecast

1Y Price Target

$990.29

Price Target Upside38.75% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering19

Eli Lilly & Co News

See All News >

Bulls Say, Bears Say

Bulls Say

Management StrategyManagement appears well positioned against potential policy changes and fundamentals are strong to grow the company for the next 5-10 years.

Market PositionThe company remains in the pole position in the anti-obesity market with a growing use case globally for its innovative portfolio of weight-loss assets where LLY is expected to remain the frontrunner.

Product EfficacyZepbound's weight loss results were superior to NVO’s Wegovy and showed a comparable tolerability.

Bears Say

Formulary ChangesLLY shares declined 11.7% due to CVS Caremark’s action favoring Wegovy over Zepbound.

Safety ConcernsThere are potential safety concerns with retatrutide, particularly regarding cardiac arrhythmias and excessive weight loss.

Stock Performance ExpectationsThe price target for Eli Lilly was lowered from $989 to $944, indicating reduced expectations for stock performance.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

10.31% Insiders

23.12% Mutual Funds

27.52% Other Institutional Investors

22.19% Public Companies and Individual Investors

Detailed Ownership Overview >

LLY FAQ

What was Eli Lilly & Co’s price range in the past 12 months?

Eli Lilly & Co lowest stock price was $677.09 and its highest was $972.53 in the past 12 months.

What is Eli Lilly & Co’s market cap?

Eli Lilly & Co’s market cap is $676.41B.

When is Eli Lilly & Co’s upcoming earnings report date?

Eli Lilly & Co’s upcoming earnings report date is Aug 07, 2025 which is in 73 days.

How were Eli Lilly & Co’s earnings last quarter?

Eli Lilly & Co released its earnings results on May 01, 2025. The company reported $3.34 earnings per share for the quarter, beating the consensus estimate of $3.258 by $0.082.

Is Eli Lilly & Co overvalued?

According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Eli Lilly & Co pay dividends?

Eli Lilly & Co pays a Quarterly dividend of $1.5 which represents an annual dividend yield of 0.76%. See more information on Eli Lilly & Co dividends here

What is Eli Lilly & Co’s EPS estimate?

Eli Lilly & Co’s EPS estimate is 5.54.

How many shares outstanding does Eli Lilly & Co have?

Eli Lilly & Co has 947,735,660 shares outstanding.

What happened to Eli Lilly & Co’s price movement after its last earnings report?

Eli Lilly & Co reported an EPS of $3.34 in its last earnings report, beating expectations of $3.258. Following the earnings report the stock price went down -11.663%.

Which hedge fund is a major shareholder of Eli Lilly & Co?

Currently, no hedge funds are holding shares in LLY

Eli Lilly & Co Stock Smart Score

Neutral

Fundamentals

Return on Equity

77.73%

Trailing 12-Months

Asset Growth

39.79%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Eli Lilly & Co

Eli Lilly & Co (LLY) is a global pharmaceutical company headquartered in Indianapolis, Indiana. The company focuses on the discovery, development, manufacturing, and marketing of pharmaceutical products. Eli Lilly is renowned for its work in the fields of endocrinology, oncology, neuroscience, and immunology, with prominent products including insulin, cancer therapies, and treatments for mental health disorders.

LLY Company Deck

LLY Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented strong financial growth driven by key products, successful trial results, and significant investments in manufacturing. However, challenges remain with regulatory hurdles, potential tariff impacts, and market dynamics in the obesity segment. The balance of positive revenue growth and strategic investments against these challenges suggests a cautiously optimistic outlook.Read More>

LLY Revenue Breakdown

67.44% U.S.

15.36% Europe

9.48% ROW

4.03% Japan

3.69% China

LLY Stock 12 Month Forecast

Average Price Target

$990.29

▲( 38.75% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"699":"$699","1134":"$1,134","807.75":"$807.8","916.5":"$916.5","1025.25":"$1,025.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1133,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.13K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":990.29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$990.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$700.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[699,807.75,916.5,1025.25,1134],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,792.48,818.6738461538462,844.8676923076923,871.0615384615385,897.2553846153846,923.4492307692308,949.6430769230769,975.8369230769231,1002.0307692307692,1028.2246153846154,1054.4184615384615,1080.6123076923077,1106.8061538461538,{"y":1133,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,792.48,807.6961538461538,822.9123076923076,838.1284615384616,853.3446153846154,868.5607692307692,883.776923076923,898.993076923077,914.2092307692308,929.4253846153846,944.6415384615384,959.8576923076923,975.0738461538461,{"y":990.29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,792.48,785.3661538461539,778.2523076923077,771.1384615384616,764.0246153846153,756.9107692307692,749.7969230769231,742.6830769230769,735.5692307692308,728.4553846153847,721.3415384615384,714.2276923076923,707.1138461538461,{"y":700,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":770.16,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 63,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":814.76,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 63,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":908.15,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":826.78,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":954.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 67,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":879.7,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 73,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":814.5,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":796.79,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":769.1,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":808.03,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":918.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":803.58,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":792.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >